[go: up one dir, main page]

PL3302463T3 - Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu - Google Patents

Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu

Info

Publication number
PL3302463T3
PL3302463T3 PL16733153T PL16733153T PL3302463T3 PL 3302463 T3 PL3302463 T3 PL 3302463T3 PL 16733153 T PL16733153 T PL 16733153T PL 16733153 T PL16733153 T PL 16733153T PL 3302463 T3 PL3302463 T3 PL 3302463T3
Authority
PL
Poland
Prior art keywords
deoxyanthocyanidins
ocular diseases
treating ocular
treating
diseases
Prior art date
Application number
PL16733153T
Other languages
English (en)
Inventor
Valérie FONTAINE
René LAFONT
José-Alain Sahel
Stanislas Veillet
Original Assignee
Biophytis
Sorbonne Universite
Centre National De La Recherche Scientifique (Cnrs)
INSERM (Institut National de la Santé et de la Recherche Médicale)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophytis, Sorbonne Universite, Centre National De La Recherche Scientifique (Cnrs), INSERM (Institut National de la Santé et de la Recherche Médicale) filed Critical Biophytis
Publication of PL3302463T3 publication Critical patent/PL3302463T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
PL16733153T 2015-05-27 2016-05-27 Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu PL3302463T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1554761A FR3036620B1 (fr) 2015-05-27 2015-05-27 Utilisation de 3-desoxyanthocyanidines pour le traitement de maladies oculaires
EP16733153.7A EP3302463B1 (fr) 2015-05-27 2016-05-27 Utilisation de 3-désoxyanthocyanidines pour le traitement de maladies oculaires
PCT/FR2016/051262 WO2016189260A1 (fr) 2015-05-27 2016-05-27 Utilisation de 3-désoxyanthocyanidines pour le traitement de maladies oculaires

Publications (1)

Publication Number Publication Date
PL3302463T3 true PL3302463T3 (pl) 2020-10-19

Family

ID=53524889

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16733153T PL3302463T3 (pl) 2015-05-27 2016-05-27 Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu

Country Status (11)

Country Link
US (1) US10513503B2 (pl)
EP (1) EP3302463B1 (pl)
JP (1) JP6738412B2 (pl)
KR (1) KR20180029978A (pl)
CN (1) CN107949382B (pl)
BR (1) BR112017025270B1 (pl)
ES (1) ES2796356T3 (pl)
FR (1) FR3036620B1 (pl)
PL (1) PL3302463T3 (pl)
RU (1) RU2730854C2 (pl)
WO (1) WO2016189260A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7537074B2 (ja) * 2016-05-10 2024-08-21 ソルボンヌ ウニベルシテ Cd47を活性化する作用物質およびその炎症治療における使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105675A (en) * 1976-03-01 1978-08-08 The Coca-Cola Company Method for making 3-deoxyanthocyanidins
WO2005077176A1 (en) 2004-02-11 2005-08-25 The Trustees Of Columbia University In The City Of New York Anthocyanin compounds and methods of use thereof
FR2975008B1 (fr) * 2011-05-13 2014-03-07 Inst Biophytis Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla)

Also Published As

Publication number Publication date
KR20180029978A (ko) 2018-03-21
JP2018515626A (ja) 2018-06-14
FR3036620B1 (fr) 2017-09-01
JP6738412B2 (ja) 2020-08-12
BR112017025270A2 (pt) 2018-08-07
EP3302463A1 (fr) 2018-04-11
RU2017145659A3 (pl) 2019-09-11
CN107949382B (zh) 2021-06-01
RU2017145659A (ru) 2019-06-27
CN107949382A (zh) 2018-04-20
ES2796356T3 (es) 2020-11-26
RU2730854C2 (ru) 2020-08-26
FR3036620A1 (fr) 2016-12-02
EP3302463B1 (fr) 2020-03-25
BR112017025270B1 (pt) 2024-01-09
WO2016189260A1 (fr) 2016-12-01
US20180230119A1 (en) 2018-08-16
US10513503B2 (en) 2019-12-24

Similar Documents

Publication Publication Date Title
IL283561B (en) Methods for treating eye diseases
HRP20190117T1 (hr) iRNK TERAPIJA ZA LIJEČENJE BOLESTI OKA
HK1258588A1 (zh) 用於治療眼科疾病的化合物和製劑
HK1246179A1 (zh) 治療視網膜疾病的方法
HK1231417A1 (zh) 用於治療眼科疾病和障礙的化合物
IL246791A0 (en) Compositions and methods for treating eye diseases
HK1258994A1 (zh) 用於疾病治療的方法
SMT202100082T1 (it) Composti eteroarilici per il trattamento di malattie oftalmiche
IL251769A0 (en) Methods for treating eye conditions
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
GB201412578D0 (en) Treatment of neurological diseases
HK1243937A1 (zh) 治療疾病的方法
IL259381B (en) Miravegron for the treatment of retinal diseases
PL3302463T3 (pl) Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu
IL263837A (en) Treatment of ocular disease
GB201610938D0 (en) Treatment of ocular disease